Related references
Note: Only part of the references are listed.Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure
Benjamin Dieplinger et al.
CLINICA CHIMICA ACTA (2009)
Only Large Reductions in Concentrations of Natriuretic Peptides (BNP and NT-proBNP) Are Associated with Improved Outcome in Ambulatory Patients with Chronic Heart Failure
Wayne L. Miller et al.
CLINICAL CHEMISTRY (2009)
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction
Milos Kubanek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure
Serge Masson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement
Richard W. Troughton et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
State of the art: Using natriuretic peptide levels in clinical practice
Alan Maisel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response - A report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
John Cleland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal Pro-B-type natriuretic peptide in patients with chronic heart failure
Stephanie Neuhold et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
Serge Masson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve
Nancy R. Cook
CLINICAL CHEMISTRY (2008)
Natriureettic peptides
Lori B. Daniels et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure
Stephan von Haehling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study
Sohail Q. Khan et al.
AMERICAN HEART JOURNAL (2007)
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker:: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial
Lars G. Olsson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T
Marco Metra et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Serial biomarker measurements in ambulatory patients with chronic heart failure - The importance of change over time
Wayne L. Miller et al.
CIRCULATION (2007)
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure -: The STARS-BNP multicenter study
Patrick Jourdain et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction Leicester acute myocardial infarction peptide (LAMP) study
Sohail Q. Khan et al.
CIRCULATION (2007)
Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure
Alfons Gegenhuber et al.
JOURNAL OF CARDIAC FAILURE (2007)
A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure
Roy S. Gardner et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure
B. Stoiser et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Direct comparison of B-Type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The valsartan heart failure (Val-HeFT) data
Serge Masson et al.
CLINICAL CHEMISTRY (2006)
Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma
Jana Papassotiriou et al.
CLINICAL CHEMISTRY (2006)
The Seattle heart failure model - Prediction of survival in heart failure
WC Levy et al.
CIRCULATION (2006)
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2006)
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2005)
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure
L Tavazzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Immunoluminometric assay for the midregion of pro-Atrial natriuretic peptide in human plasma
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2004)
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
IS Anand et al.
CIRCULATION (2003)
Measurement of endothelin: clinical and research use
GP Rossi et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2000)
Share Paper
